Detection of non inhibitory binding antibodies to von Willebrand factor affecting the clearance of VWF:Ag in von Willebrand disease

被引：0

作者：

Suiter, T. M. ^{[1
]}

Mannucci, P. M. ^{[2
]}

Kempton, C. ^{[3
,4
]}

Laffan, M. ^{[5
]}

Romond, E. H. ^{[6
]}

Shapiro, A. ^{[7
]}

Birschmann, I. ^{[8
]}

Ragni, M. V. ^{[9
,10
]}

Gill, J. C. ^{[11
]}

Yee, T. T. ^{[12
,13
]}

Klamroth, R. ^{[14
]}

Horling, F. M. ^{[15
]}

Reipert, B. M. ^{[15
]}

Turecek, P. L. ^{[1
]}

Varadi, K. ^{[1
]}

Chapman, M. ^{[1
]}

Engl, W. ^{[1
]}

Wong, W. Y.

Ewenstein, B. M.

机构：

[1] Baxter Innovat GmbH, Vienna, Austria

[2] Univ Milan, A Bianchi Bonomi Hemophilia & Thrombosis Ctr, I-20122 Milan, Italy

[3] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA

[4] Emory Univ, Sch Med, Dept Hematol Oncol, Atlanta, GA USA

[5] Hammersmith Hosp, Imperial Coll Sch Med, Dept Hematol, London, England

[6] Univ Kentucky, Hemophilia Treatment Ctr, Lexington, KY 40506 USA

[7] Indiana Hemophilia & Thrombosis Ctr, Indiana, PA USA

[8] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, D-3000 Hannover, Germany

[9] Univ Pittsburgh, Pittsburg, KS USA

[10] Hemophilia Ctr Western Penn, Dept Med, Div Hematol Oncol, Pittsburg, KS USA

[11] Med Coll Wisconsin, Milwaukee, WI 53226 USA

[12] Royal Free Hosp, Haemophilia Ctr, London NW3 2QG, England

[13] Royal Free Hosp, Thrombosis Unit, London NW3 2QG, England

[14] Vivantes Klinikum Friedrichshain, Klin Innere Med Angiol & Haemostaseol, Berlin, Germany

[15] Baxter BioSci, Immunol, Vienna, Austria

来源：

HAEMOPHILIA | 2012年 / 18卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：42 / 43

页数：2

共 50 条

[31] A mutation in the D4 domain of von Willebrand factor (VWF) results in a variant of type 1 von Willebrand disease with accelerated in vivo VWF clearance. [J].

Gavazova, S ;

Gill, JC ;

Scott, JP ;

Hillery, CA ;

Friedman, KD ;

Wetzel, N ;

Jozwiak, M ;

Haberichter, SL ;

Christopherson, P ;

Montgomery, RR .

BLOOD, 2002, 100 (11) :128A-128A

[32] Acquired von Willebrand disease: potential contribution of the von Willebrand factor collagen-binding to the identification of functionally inhibiting auto-antibodies to von Willebrand factor: a rebuttal [J].

Guerin, V. ;

Ryman, A. ;

Velez, F. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2008, 6 (06) :1051-1052

[33] The challenging management of a child with type 3 von Willebrand disease and antibodies to von Willebrand factor [J].

Pergantou, H. ;

Xafaki, P. ;

Adamtziki, E. ;

Koletsi, P. ;

Komitopoulou, A. ;

Platokouki, H. .

HAEMOPHILIA, 2012, 18 (03) :e66-e67

[34] Von Willebrand Factor and von Willebrand disease: prerequisite for diagnostic [J].

Fressinaud, Edith .

HEMATOLOGIE, 2014, 20 :6-13

[35] von Willebrand disease and quantitative variation in von Willebrand factor [J].

Mohlke, KL ;

Ginsburg, D .

JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1997, 130 (03) :252-261

[36] Comparison between plasma von Willebrand factor (VWF) and VWF antigen II level in normal individuals and patients with von Willebrand disease [J].

DeRomeuf, C ;

Mazurier, C .

BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 :640-640

[37] Von Willebrand factor's clearance [J].

Denis, Cecile V. ;

Lenting, Peter J. .

HEMATOLOGIE, 2006, 12 (01) :34-43

[38] The Y/C1584 mutation of von Willebrand factor in type 2M von willebrand disease: frequency and clearance of von Willebrand factor [J].

Millar, CM ;

Riddel, AF ;

Griffioe, A ;

Jenkin, PV ;

Brown, SA .

BRITISH JOURNAL OF HAEMATOLOGY, 2005, 130 (03) :462-463

[39] The role of VWF:Ag II in patients with acquired von Willebrand disease [J].

Krause, M ;

Caron, C ;

Stier-Brück, I ;

Vigh, T ;

Scharrer, I .

34th Hemophilia Symposium, 2005, :207-211

[40] INHIBITION OF WILLEBRAND FACTOR IN VON WILLEBRAND DISEASE [J].

MARAGALL, S ;

CASTILLO, R ;

ORDINAS, A ;

LIENDO, F ;

RODRIGUEZ, M .

THROMBOSIS RESEARCH, 1979, 14 (2-3) :495-500

← 1 2 3 4 5 →